Insulin resistance and plasma triglycerides level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects

Vascular Health and Risk Management

Volumn 2, Issue 4, 2006, Pages 485-490

  Legedz, Liliana ^a,b   Bricca, Giampiero ^b   Lantelme, Pierre ^a   Rial, Marie Odile ^a   Champomier, Pierre ^a   Vincent, Madeleine ^b   Milon, Hugues ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Arterial stiffness; Cardiac hypertrophy; Insulin resistance

Indexed keywords

ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NORMETADRENALIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

ARTERIES; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOMEGALY; CHOLESTEROL, HDL; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PULSATILE FLOW; SYNDROME; TRIGLYCERIDES; VENTRICULAR REMODELING;

EID: 33846928770     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2006.2.4.485     Document Type: Article

References (35)

1. Amar J, Ruidavets JB, Chamontin B, et al. 2001. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens, 19:381-7.
2. Asmar RG, Benetos A, Topouchian J, et al. 1995. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension, 26:485-90.
3. Barger PM, Brandt JM, Leone TC, et al. 2000. Deactivation of peroxisome proliferator-activated receptor α during cardiac hypertrophic growth. J Clin Invest, 105:1723-30.
4. Blacher J, Asmar R, Djane S, et al. 1999. Aortic pulse wave velocity as a marker of cardiovascular risk in hypeternsive patients. Hypertension, 33:1111-7.
5. Bussy C, Boutouyrie P, Lacolley P, et al. 2000. Intrinsic stiffness of the carotid arterial wall in essential hypertensives. Hypertension, 35:1049-54.
6. Bouguerra SA, Bourdillon MC, Dahmani Y, et al. 2001. Non insulin-dependent diabetes in Sand rat (Psammomys obesus) and production of collagen in cultured aortic smooth muscle cells. Influence of insulin. Int J Exp Diabetes Res, 2:37-46.
7. Campbell FM, Kozak R, Wagner A, et al. 2002. A role for PPARα in the control of cardiac Malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentration of Malonyl-CoA and reduced expression of Malonyl-CoA decarboxylase. J Biol Chem, 277:4098-103.
8. Davis CL, Kapuku G, Snieder H, et al. 2002. Insulin resistance syndrome and left ventricular mass in healthy young people. Am J Med Sci, 324:72-5.
9. Devereux RB, Roman MJ, Paranicas M, et al. 2000. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation, 101:2271-6.
10. Ferreira I, Henry RM, Twisk JW, et al. 2005. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med, 165:875-82.
11. Galvan AQ, Galetta F, Natali A, et al. 2000. Insulin resistance and hyperinsulinemia. No independent relation to left ventricular mass in humans. Circulation, 102:2233-9.
12. Ginsberg HN. 2000. Insulin resistance and cardiovascular disease. J Clin Invest, 106:453-8.
13. Grossman E, Shemesh J, Shamiss A, et al. 1992. Left ventricular mass in diabetes-hypertension. Arch Intern Med, 152:1001-4.
14. Guida L, Celentano A, Iannuzzi R, et al. 2001. Insulin resistance, ventricular mass and function in normoglycemic hypertensives. Nutr Metab Cardiovascular Dis, 11:306-11.
15. Harano Y, Suzuki M, Shinozaki K, et al. 1996. Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach. Hypertens Res, 19:S81-5.
16. HOPE Study Investigators. 2000. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on death from cardio-vascular causes, myocardial infarction and stroke in high-risk patients. N Engl J Med, 342:145-52.
17. Kelly DP. 2002. Peroxisome Proliferator-Activated Receptor α as a genetic determinant of cardiac hypertrophic growth. Culprit or innocent bystander. Circulation, 105:1025-30.
18. Lauer MS, Anderson KM, Kannel WB, et al. 1991. The impact of obesity on left ventricular mass and geometry. JAMA, 226:231-6.
19. Legedz L, Rial MO, Lantelme P, et al. 2003. Markers of cardio-vascular remodeling in hypertension. Arch Mal Coeur, 96:729-33.
20. Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al. 2002. Correlates of aortic stiffness in elderly individuals: a subgroup of the cardiovascular health study. Am J Hypertens, 15:16-23.
21. Malmqvist K, Ohman KP, Lind L, et al. 2002. Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin. J Int Med, 252:430-6.
22. Matthews DR, Hosker JP, Rudenski AS, et al. 1985. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28:412-9.
23. Olsen MH, Fossum E, Hjerkinn E, et al. 2000. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE substudy. Insulin CARotids US Scandinavia. J Hypertens, 18:75-81.
24. Olsen MH, Hjerkinn E, Wachtell K, et al. 2003. Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension. ICARUS: a L1FE substudy. J Hum Hypertens, 17:305-11.
25. Palmieri V, de Simone G, Roman MJ, et al. 1999. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension, 34:1032-40.
26. Palmieri V, Bella JN, Arnett DK, et al. 2001. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation, 103:102-10.
27. Paolisso G, Galderisi M, Tagliamonte MR, et al. 1997. Myocardial wall thickness and left ventrieular geometry in hypertensives. Relationship with insulin. Am J Hypertens, 10:1250-6.
28. Rutter MK, Parise H, Benjamin EJ, et al. 2003. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation, 107:448-54.
29. Sack MN, Rader TA, Park S, et al. 1996. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation, 94:2837-42.
30. Salomaa V, Riley W, Kark JD, et al. 1995. Non insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 91:1432-43.
31. Stout RW. 1992. Insulin and atherogenesis. Eur J Epidemiol, 8:134-5.
32. Sundstrom J, Lind L, Nystrom N, et al. 2000a. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation, 101:2595-600.
33. Sundstrom J, Lind L, Vessby B, et al. 2000b. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation, 103:836-41.
34. UK Prospective Diabetes Study Group. 1998. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352:837-53.
35. van Dijk RA, Bakker SJ, Scheffer PG, et al. 2003. Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Invest, 33:307-15.